ScholarIQanswers from OpenAlex & ORCID
Amr Makady
ResearcherPublications, citations & collaboration network
Amr Makady is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Amr Makady have?
ScholarIQindexed works
Amr Makady has 46 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Amr Makady have?
ScholarIQcitation count
Amr Makady has 1,981 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Amr Makady?
ScholarIQh-index
Amr Makady has an h-index of 16 in OpenAlex.
What is the i10-index of Amr Makady?
ScholarIQi10-index
Amr Makady has an i10-index of 22 in OpenAlex.
What is the ORCID of Amr Makady?
ScholarIQorcid
The ORCID for Amr Makady is on the source record.
What is the OpenAlex record for Amr Makady?
ScholarIQopenalex
The OpenAlex for Amr Makady is on the source record.
What are the most-cited papers on Amr Makady?
ScholarIQmost cited works
Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making
Marc L. Berger, Harold C. Sox, Richard J. Willke, Diana Brixner, Hans‐Georg Eichler, Wim Goettsch, David Madigan, Amr Makady, Sebastian Schneeweiß, Rosanna Tarricone, Shirley Wang, John B. Watkins, C. Daniel Mullins
What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
Amr Makady, Anthonius de Boer, Hans L. Hillege, Olaf H. Klungel, Wim Goettsch
Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint <scp>ISPOR‐ISPE</scp> Special Task Force on real‐world evidence in health care decision making
Marc L. Berger, Harold C. Sox, Richard J. Willke, Diana Brixner, Hans‐Georg Eichler, Wim Goettsch, David Madigan, Amr Makady, Sebastian Schneeweiß, Rosanna Tarricone, Shirley Wang, John B. Watkins, C. Daniel Mullins
Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
Amr Makady, Renske M.T. ten Ham, Anthonius de Boer, Hans L. Hillege, Olaf H. Klungel, Wim Goettsch
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Shirley Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiß, REPEAT Initiative, Jessica M. Franklin, Joshua J. Gagne, Krista F. Huybrechts, Elisabetta Patorno, Yinzhu Jin, Moa Lee, Mufaddal Mahesri, Ajinkya Pawar, Julie Barberio, Lily G. Bessette, Kristyn Chin, Nileesa Gautam, Adrian Santiago Ortiz, Ellen Sears, Kristina Stefanini, Mimi Zakarian, Sara Z. Dejene, James R. Rogers, Gregory Brill, Joan Landon, Joyce Lii, Theodore Tsacogianis, Seanna Vine, Elizabeth M. Garry, Liza R. Gibbs, Monica Gierada, Danielle L. Isaman, Emma Payne, Sarah Alwardt, Peter Arlett, Dorothee B. Bartels, Andrew Bate, Jesse A. Berlin, Alison Bourke, Brian D. Bradbury, Jeffrey S. Brown, K.L. Burnett, Troyen A. Brennan, K. Arnold Chan, Nam‐Kyong Choi, Frank de Vries, Hans‐Georg Eichler, Kristian B. Filion, Lisa Freeman, Jesper Hallas, Laura E. Happe, Sean Hennessy, Páll Jónsson, John P. A. Ioannidis, Javier Jiménez, Kristijan H. Kahler, Christine Laine, Elizabeth Loder, Amr Makady, David Martin, Michael Nguyen, Brian A. Nosek, Richard Platt, Robert W. Platt, John D. Seeger, William H. Shrank, Liam Smeeth, Henrik Toft Sørensen, Peter Tugwell, Yoshiaki Uyama, Richard J. Willke, Wolfgang C. Winkelmayer, Deborah A. Zarin